Baheal Medical: Signed a strategic cooperation agreement with Jikun Pharmaceutical

Baheal Medical announced that the company has signed a strategic cooperation agreement with Jikun Pharmaceutical and its actual controller. According to the agreement, Baheal Medical plans to participate in the capital increase and share expansion of Jikun Pharmaceutical, and is expected to hold 24% of the equity in Jikun Pharmaceutical. This cooperation aims to leverage the resource advantages of both parties and expand the company's product pipeline in the field of innovative drugs. The agreement is expected not to have a significant impact on the company's operating performance for this year, but will be beneficial in enhancing the company's sustainable profitability